| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 611.819 | 620.489 | 668.643 | 735.396 | 747.726 | 737.878 | 239.797 | 201 | 508 | 0 |
| Total Income - EUR | 611.833 | 626.157 | 668.719 | 736.101 | 756.407 | 756.194 | 327.557 | 417 | 508 | 0 |
| Total Expenses - EUR | 560.009 | 576.349 | 603.484 | 682.253 | 731.552 | 716.724 | 289.654 | 1.265 | 2.912 | 0 |
| Gross Profit/Loss - EUR | 51.824 | 49.809 | 65.234 | 53.849 | 24.855 | 39.470 | 37.903 | -848 | -2.404 | 0 |
| Net Profit/Loss - EUR | 44.048 | 41.162 | 54.281 | 46.287 | 17.644 | 33.773 | 33.609 | -860 | -2.404 | 0 |
| Employees | 11 | 11 | 12 | 13 | 13 | 12 | 3 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacia Sarkadi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 48.888 | 34.801 | 26.411 | 24.796 | 23.381 | 21.098 | 0 | 0 | 0 | 0 |
| Current Assets | 205.658 | 239.694 | 257.482 | 292.000 | 254.460 | 265.004 | 156.594 | 64.321 | 11.838 | 11.772 |
| Inventories | 123.491 | 143.252 | 122.315 | 133.827 | 113.870 | 119.589 | 0 | 0 | 0 | 0 |
| Receivables | 49.355 | 37.275 | 80.575 | 112.017 | 78.430 | 89.662 | 6.597 | 6.732 | 4.644 | 4.619 |
| Cash | 32.812 | 59.166 | 54.592 | 46.156 | 62.160 | 55.753 | 149.996 | 57.589 | 7.194 | 7.154 |
| Shareholders Funds | 207.731 | 41.268 | 94.850 | 139.397 | 115.823 | 147.401 | 156.462 | 64.303 | 7.450 | 7.408 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 46.815 | 233.227 | 189.042 | 177.399 | 162.018 | 138.840 | 132 | 18 | 4.389 | 4.364 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8211 - 8211" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Sarkadi Srl